PKM2 acts like a switch for cellular energy, directly determining whether cancer cells can rapidly generate energy and biosynthetic precursors to support their continued growth. Using a driving ...

Please provide your email address to receive an email when new articles are posted on . ATLANTA — Parabens, a class of endocrine-disrupting chemicals widely found in hair and personal care products, ...

Researchers are one step closer to providing a new therapy for colon cancer, after findings revealed that a small molecule focal adhesion kinase (FAK) inhibitor known as Y15 effectively blocked cell ...

Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. Included were 63 patients with primary breast cancer (a), 27 with metastatic ...

As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. advisor to look at the effects on cell viability by an untested drug we suspect inhibits ...

Vik Bajaj, managing director at venture capitalist firm Foresite Capital and CEO of Foresite Labs, which focuses on transforming healthcare through data-driven solutions, sat down with MobiHealthNews ...

A microarray approach to identify vorinostat-restored signaling pathways in leukemia cells. Background: Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is overexpressed of a variety ...

Novel Concepts Medical is proud to announce breakthrough results from its labs in Israel showing that its plant-based formula resulted in over 99% decrease in cell viability of breast cancer cells and ...

However, there are only few data on the effect of proteasome inhibitors in prostate cancer cells derived from primary culture as well as the influence of antiandrogens in this setting. The current ...

In vitro aggregates of stem cells and tumor cells called spheroids have been used for decades as models to recapitulate the in vivo tissue environment. Spheroids can be established from a single cell ...

In a recent study, Prokop et al. used the CASY Cell Counter and Analyzer from Roche Applied Science to identify the specific anticancer properties of a therapeutic substance in Burkitt-like lymphoma ...